KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding KALA BIO, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 30 | 1 | 24 | −5 |
| Shares | 3.64M | 25 | 1.75M | −1.89M (−52.0%) |
| Value | $17.3M | $119 | $2.69M | −$14.6M (−84.5%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held KALA BIO, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 28,576 | $43.7K | 0.00% |
| Marex Group plc | 14,500 | $35.0K | 0.00% |
| Caitong International Asset Management Co., Ltd | 736 | $1.13K | 0.00% |
| Citigroup Inc | 721 | $1.10K | 0.00% |
| The PNC Financial Services Group, Inc. | 46 | $70 | 0.00% |
Sold out (10)
Institutions that held KALA BIO, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Cormorant Asset Management, LP | 603,027 | $2.87M |
| Sr One Capital Management, LP | 598,940 | $2.85M |
| AIGH Capital Management LLC | 300,000 | $1.43M |
| UBS Oconnor LLC | 138,556 | $659.5K |
| Perceptive Advisors LLC | 55,227 | $262.9K |
| Renaissance Technologies LLC | 17,400 | $82.8K |
| XTX Topco Ltd | 12,990 | $61.8K |
| Advisor Group Holdings, Inc. | 100 | $476 |
| BNP Paribas Arbitrage, SA | 98 | $466 |
| Raymond James Financial Inc | 7 | $33 |
Not filed for Q3 2025 yet (1)
Institutions that held KALA BIO, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Legacy Investment Solutions, LLC | 25 | $119 |